Companies / California / iSchemaView

· rebuilt nightly from public records

Signal Sheet

Selling to iSchemaView? Who to reach and why now

Headquartered in Menlo Park, California, iSchemaView is a private health care company. It raised $25M in Feb 2026, has 10 open roles and its filings name 8 officers. Everything below links to the record it came from.

Private company · Health Care · California

For sellersWhy iSchemaView is worth a call this quarterBuy Window: watching
10Nov 2026

Building a team

Open roles on the company's own careers page, read nightly.

Hiring
$25M

New budget

Equity raise reported to the SEC, Feb 2026.

Capital
Track iSchemaView with a free trial →Get the next signal the day it is filed or posted.
Sell to companies like this?

Select your targets, see why-now for every account

Pick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.

Want this matched to what you sell? Get early access to Pursuit Plans →
Start your free trial →

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 5, 202610 open rolesHiringCareers page
Feb 17, 2026Raised $25M in equity from 1 investorsCapitalSEC filing

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerKarim KartiSEC filing, Feb 2026Named officer in the filing; part of the buying group
Executive OfficerDavid StoffelSEC filing, Feb 2026Named officer in the filing; part of the buying group
Chief Technology OfficerGregory W. AlbersSEC filing, Feb 2026Technology and tooling decisions
Chief Technology OfficerRoland BammerSEC filing, Feb 2026Technology and tooling decisions
Chief Technology OfficerJohn DrewSEC filing, Feb 2026Technology and tooling decisions
Chief Technology OfficerErol Ali DervisSEC filing, Feb 2026Technology and tooling decisions
Chief Technology OfficerMark S. BrandinSEC filing, Feb 2026Technology and tooling decisions
Chief Technology OfficerBrendan RenehanSEC filing, Feb 2026Technology and tooling decisions
Showing 3 of 8Start a free trial to see all 8 →

Reach iSchemaView with emails that land

Lakewave finds the right people at iSchemaView, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on iSchemaView with a free trial →

About iSchemaView

HeadquartersMenlo Park, California, per the filing address
Industry groupOther Health Care
OwnershipPrivate company
Raise history$25M (Feb 2026)
Lakewave Rising21 · 2 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Ensysce Biosciences · 37Tenon Medical · 359amhealth · 27Alpfa Medical · 21Pfaradigm Health · 18Hawthorne Health · 18See all 6 with a free trial →

Questions people ask

Did iSchemaView raise funding in 2026?

Yes. iSchemaView reported a $25M equity raise to the SEC on Feb 17, 2026 with 1 investors.

Who runs iSchemaView?

The company's SEC filing, Feb 2026 names Karim Karti (Executive Officer) among its officers.

Is iSchemaView hiring?

Yes. 10 roles were open on its careers page on Nov 11, 2026.

Where is iSchemaView headquartered?

Menlo Park, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 11, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.